# Soleno Therapeutics, Inc. Common Stock (SLNO)

Soleno Therapeutics (SLNO) faces social media concerns over trial endpoints, impacting its stock price despite positive analyst ratings and acquisition rumors. The company's social dominance has surged significantly, indicating increased online attention.

### About Soleno Therapeutics, Inc. Common Stock
Soleno Therapeutics, Inc. Common Stock is a pharmaceutical company focused on developing treatments for rare diseases.  
Soleno Therapeutics, Inc. Common Stock uses the ticker $SLNO for trading. Listed in the [Stocks](/list/stocks) category.

### Insights
- Soleno Therapeutics, Inc. Common Stock (SLNO) social dominance hit [------] which is 759% higher than it's daily average.
- Soleno Therapeutics, Inc. Common Stock (SLNO) social dominance is up 1895.16% from the previous year.
- Soleno Therapeutics, Inc. Common Stock (SLNO) engagements is up 41.37% from the previous week.
- Soleno Therapeutics, Inc. Common Stock (SLNO) mentions is up 43.5% from the previous month.

### Price: $37.20
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$slno/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$slno/time-series/close.tsv)  
The stock price has seen a recent decrease, attributed to social media concerns regarding trial endpoints, which have overshadowed positive analyst ratings and acquisition rumors. This has led to the stock nearing a 52-week low in market dominance.  

24-Hour: -3.18%
7-Day: -8.64%
30-Day: -12.34%

1-Year High: $88.50 on 2025-07-09  
1-Year Low: $37.20 on 2026-02-13  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$slno/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$slno/time-series/alt_rank.tsv)  
Soleno Therapeutics, Inc. Common Stock (SLNO) is currently AltRank #662 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] +197  
[--] Month: [---] +329  
[--] Months: [---] +811  
1-Year High: [-----] on 2025-07-27  
1-Year Low: [--] on 2025-11-06  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$slno/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$slno/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] +20  
[--] Months: [--] [---]  
1-Year High: [--] on 2025-05-15  
1-Year Low: [--] on 2025-09-15  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$slno/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$slno/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [------] +41%  
[--] Month: [-------] -58%  
[--] Months: [---------] +99%  
[--] Year: [---------] +409%  
1-Year High: [-------] on 2025-11-04  
1-Year Low: [---] on 2025-06-01  

Engagements by network (24h):
News: [--]
YouTube: [--]
TikTok: [--]
X: [-----]
Instagram: [--]
Reddit: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$slno/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$slno/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [---] +14%  
[--] Month: [---] +44%  
[--] Months: [-----] +25%  
[--] Year: [-----] +349%  
1-Year High: [---] on 2025-11-08  
1-Year Low: [--] on 2025-09-06  

Mentions by network (24h):
News: [--]
YouTube: [--]
TikTok: [--]
X: [---]
Instagram: [--]
Reddit: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$slno/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$slno/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Soleno Therapeutics, Inc. Common Stock (SLNO) in the last [--] hours which is down 43% from [---] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] +8.20%  
[--] Month: [---] +49%  
[--] Months: [---] -27%  
[--] Year: [-----] +204%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-02-16  

The most influential creators that mention Soleno Therapeutics, Inc. Common Stock in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@seedy19tron](/creator/twitter/seedy19tron)         | [--]    | [------]    | [--]    | [-----]       |
| [@BOSSTRADING0](/creator/twitter/BOSSTRADING0)       | [--]    | [-----]     | [--]     | [-----]       |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--]    | [-----]     | [--]     | [---]         |
| [@semodough](/creator/twitter/semodough)             | [--]    | [------]    | [--]     | [---]         |
| [@jmli19698](/creator/twitter/jmli19698)             | [--]    | [--]        | [--]     | [---]         |
| [@ElMonoGran42994](/creator/twitter/ElMonoGran42994) | [--]    | [---]       | [--]     | [--]          |
| [@DeepSouthDoctor](/creator/twitter/DeepSouthDoctor) | [--]    | [-----]     | [--]     | [--]          |
| [@FRlyeh75577](/creator/twitter/FRlyeh75577)         | [--]    | [--]        | [--]     | [--]          |
| [@Trade_market1](/creator/twitter/Trade_market1)     | [--]    | [---]       | [--]     | [--]          |
| [@Gail83074716726](/creator/twitter/Gail83074716726) | [--]   | [--]        | [--]     | [--]          |

[View More](/list/creators/$slno/100)
  
  
### Sentiment: 69%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$slno/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$slno/time-series/sentiment.tsv)  
Current Value: 69%  
Daily Average: 79%  
[--] Week: 86% -14%  
[--] Month: 67% -1%  
[--] Months: 67% -14%  
[--] Year: 67% -21%  
1-Year High: 100% on 2025-03-02  
1-Year Low: 22% on 2025-09-10  

Most Supportive Themes:
- Goldman Sachs Initiates Buy Rating: (10%) Goldman Sachs has initiated coverage of Soleno Therapeutics with a Buy rating, signaling positive institutional sentiment.
- Competitor Setback: (15%) A competitor's setback in a similar therapeutic area is likely contributing to positive market share gains for Soleno Therapeutics.
- Acquisition Rumors: (20%) Speculation about potential acquisition of Soleno Therapeutics is circulating, driven by rumors and analyst reports, suggesting investor interest.
  
Most Critical Themes:
- Recent Price Decrease: (5%) The stock price has experienced a decrease in the last [--] hours, indicating recent negative price action.
- Negative Sentiment Shift: (10%) Despite overall positive sentiment, recent negative sentiment and a price decrease suggest potential volatility and a possible correction.
  
  
  
### Social Dominance: 0.01%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$slno/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$slno/time-series/social_dominance.tsv)  
Current Value: 0.01%  
Daily Average: 0.014%  
[--] Week: 0.014% +0.01%  
[--] Month: 0.124% +0.107%  
[--] Months: 0.124% +0.107%  
[--] Year: 0.124% +0.118%  
1-Year High: 0.124% on 2026-02-15  
1-Year Low: 0.0037% on 2025-12-27  
  
  
### Market Dominance: 0.00227%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$slno/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$slno/time-series/market_dominance.tsv)  
Current Value: 0.00227%  
Daily Average: 0%  
1-Year High: 0.138% on 2025-07-09  
1-Year Low: 0.00227% on 2026-02-14  
  
  
### Market Cap: $2,008,754,935
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$slno/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$slno/time-series/market_cap.tsv)  
Current Value: $2,008,754,935  
Daily Average: $3,332,382,905  
[--] Week: $2,008,754,935 -8.90%  
[--] Month: $2,000,161,331 -11%  
[--] Months: $2,000,161,331 -45%  
1-Year High: $4,667,570,703 on 2025-07-09  
1-Year Low: $2,000,161,331 on 2026-02-13  

### Top Soleno Therapeutics, Inc. Common Stock Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"DEEP TRACK UPDATES 13F $XBI $IBB NEW POSITIONS: $VERA $GRAL $MLTX $ALKS $CNTA $SLNO $VSTM $ENTA $ATAI $COGT $NMPR $BLLN $IVA $JANX $ANL INCREASED $IMVT $TARS $AXSM $PCVX $MAZE $BMRN $NRIX $MBX $IMCR $CRMD $DYN $BCAX $ENGN $ANIP $DFTX $TNGX $XFOR $HELP"  
[X Link](https://x.com/BOSSTRADING0/status/2022712482217775598) [@BOSSTRADING0](/creator/x/BOSSTRADING0) 2026-02-14T16:40Z [----] followers, [----] engagements


"$SLNO market cap as multiples of analyst consensus v. [--] peers acquired w/very similar revenue $ forecasts. All were acquired @ multiples 3X+ higher suggesting if SLNO analysts are credible & if Vykat is worth peer multiples (2 BIG IFs) then. Note SLNO gross margin $XBI $IBB"  
[X Link](https://x.com/NightOwlBiotech/status/2022671352336146662) [@NightOwlBiotech](/creator/x/NightOwlBiotech) 2026-02-14T13:56Z [----] followers, [---] engagements


"No update for a bit lets talk: This year Im modifying my approach and will be focusing on high conviction plays and holding a significant cash stack. I am about 70% cash currently and holding onto it for good opportunities. I closed a vast majority of my positions but I wont spend too much time on those in this post. Here is where I currently stand: Long: $BBIO $CRNX $SLNO These are long term holds. I intend to hold onto both $BBIO and $CRNX for years to come and I think both have fantastic potential as long as they continue to execute. $BBIO is my largest position by quite a bit and I have"  
[X Link](https://x.com/augurbio/status/2022508788771651926) [@augurbio](/creator/x/augurbio) 2026-02-14T03:10Z [---] followers, [----] engagements


"The Weekly 🌱 New: $anl $tern $cmps Increased: $abvx $nktr Unchanged: $nxtc $ovid $slno $cntx $pasg $dawn $lqda $rytm Decreased: Closed: $crvs (s) $apge (s) $asnd $ptn $cogt Feels like forever since the last weekly but nice to get back to work. The past week felt like a movie but important to not get distracted. Long weekend ahead with markets being closed on Monday so will use this time to get back up to speed and work on a few new ideas. $iron CRL ngl was a surprise but Im glad I passed on it even though there were rumours that approval was a foregone conclusion. $goss and $ocul should be"  
[X Link](https://x.com/seedy19tron/status/2022408965443768541) [@seedy19tron](/creator/x/seedy19tron) 2026-02-13T20:34Z 14.2K followers, 13.2K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing